BBNX
NASDAQ
$17.82
Beta Bionics Inc (BBNX)
Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. The company is headquartered in Irvine, California.
Sector:
Healthcare
Industry:
Medical Devices
Buy
Target: $19.80 (+11.11%)
Market Cap
$751M
Free Cash Flow Yield
-8.14%
Beta (5Y)
1.68
Price Chart
Valuation
Market Cap$751M
P/S6.82
P/B2.77
Profitability
Total Revenue (TTM)$110M
Gross Profit (TTM)$63M
EBITDA-$75M
Profit Margin-79.3%
Operating Margin-87.9%
EPS-$1.51
Financial Health
Free Cash Flow Yield-8.14%
Growth & Risk
Beta (5Y)1.68
Sharpe Ratio0.76